Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

XR-NTX

Small molecule

Phase 4 Most advanced trial
1 Registered trials

What is XR-NTX?

XR-NTX is given as two intramuscular injections of 380 mg in a trial of alcohol use disorder.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Therapy area
Psychiatry
In trials of
ALKS
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 4

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05028062 Phase 4 Alcohol Use Disorder Recruiting ALKS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Alcohol Use DisorderAlcoholism

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.